Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex

Approvals Action
Pfizer vs Humira

Posted 1 March 2021 

Pfizer's Abrilada has been approved by the TGA adding to a growing list of adalimumab biosimilars marketed in Australia.

Available as solution for injection vial, pre-filled pen and pre-filled syringe, Abrilada is indicated for the same inflammatory diseases as AbbVie's originator Humira.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas